Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : OmniCorder Technologies, Inc. (OMCT) -- Ignore unavailable to you. Want to Upgrade?

To: RikRichter who wrote (47)	8/16/2004 11:24:37 PM
From: Mahatmabenfoo	Respond to of 63

Rik, why don't you get it? This doggie hasn't traded at all since August 9th! (today is the 16th). You think it's going to get on AMEX??? It's more likely to get delisted. They you quote this from the 10Q like it means something: "The BioScanIR System has received FDA Section 510(k) clearance permitting its sale in the US, and CE mark approval permitting its sale in Europe" You're kidding, right? or you don't read my posts. This company has had stuff for sale FOR FOUR YEARS and has no sales, and has half the staff it used to have (a paltry 11 or so employees). The "now for sale" hype is old -- this company can't even think of new ways to beat this dead horse. And YOU are the guy so excited about this stock you boasted about it in a bunch of online forums. Zowie! - Charles

To: RikRichter who wrote (47)	10/24/2004 11:40:01 PM
From: Mahatmabenfoo	Respond to of 63

Well, now the result of all of OMCT's recent presentations to analysts has become clearer: closing price on 10/22/04 was $0.75. All anyone had to do to understand this company is learn a little of its history. The fact it claims to have a product "FDA" approved becomes a bad thing when you realize it has no sales. When you realize made no sales for YEARS after FDA approval, and now has fewer than half the employees of a few years ago, you'd know this doggie is not on the way up. But hey, they WERE able to give away a machine. At least someone took it for free. - Charles EAST SETAUKET, N.Y., Oct 14, 2004 (BUSINESS WIRE) -- OmniCorder Technologies, Inc. (OTCBB Symbol: OMCT) today announced the delivery of their new cancer therapy monitoring configuration of the BioScanIR(R) System to Italy's National Tumor Institute in Milan.